Post-translational Modifications of Recombinant Proteins: Significance for Biopharmaceuticals

The production of recombinant therapeutic proteins is one of the fastest growing sectors of the pharmaceutical industry, particularly monoclonal antibodies and Fc-fusion proteins. Currently, mammalian cells are the dominant production system for these proteins because they can perform complex post-translational modifications that are often required for efficient secretion, drug efficacy, and stability. These protein modifications include misfolding and aggregation, oxidation of methionine, deamidation of asparagine and glutamine, variable glycosylation, and proteolysis. Such modifications not only pose challenges for accurate and consistent bioprocessing, but also may have consequences for the patient in that incorrect modifications and aggregation can lead to an immune response to the therapeutic protein. This mini-review describes examples analytical and preventative advances in the fields of protein oxidation, deamidation, misfolding and aggregation (glycosylation is covered in other articles in this issue). The feasibility of partially replacing traditional analytical methods such as peptide mapping with high-throughput screens and their use in clone and media selection are evaluated. This review also discusses how further technical advances could improve the manufacturability, potency, and safety of biotherapeutics.

[1]  C. Ionescu-Zanetti,et al.  Mechanism of thioflavin T binding to amyloid fibrils. , 2005, Journal of structural biology.

[2]  A. Pekar,et al.  Quantitation of aggregates in therapeutic proteins using sedimentation velocity analytical ultracentrifugation: practical considerations that affect precision and accuracy. , 2007, Analytical biochemistry.

[3]  C. Hollenberg,et al.  Expression of mouse anticreatine kinase (MAK33) monoclonal antibody in the yeast Hansenula polymorpha , 2001, Applied Microbiology and Biotechnology.

[4]  M. Mann,et al.  Selective deamidation of recombinant human stem cell factor during in vitro aging: isolation and characterization of the aspartyl and isoaspartyl homodimers and heterodimers. , 1998, Biochemistry.

[5]  S. Frokjaer,et al.  Effects of sucrose on rFVIIa aggregation and methionine oxidation. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[6]  A. Helenius,et al.  Chaperone selection during glycoprotein translocation into the endoplasmic reticulum. , 2000, Science.

[7]  D. Ejima,et al.  Review: Why is arginine effective in suppressing aggregation? , 2005, Protein and peptide letters.

[8]  A. Dickson,et al.  Mammalian cell factories for efficient and stable protein expression. , 2006, Current opinion in biotechnology.

[9]  B. Kabakoff,et al.  Identification of multiple sources of charge heterogeneity in a recombinant antibody. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[10]  Katie F Wlaschin,et al.  EST sequencing for gene discovery in Chinese hamster ovary cells. , 2005, Biotechnology and bioengineering.

[11]  N. Bulleid,et al.  The role of glutathione in disulphide bond formation and endoplasmic‐reticulum‐generated oxidative stress , 2006, EMBO reports.

[12]  Huub Schellekens,et al.  Structure-Immunogenicity Relationships of Therapeutic Proteins , 2004, Pharmaceutical Research.

[13]  P. Roach,et al.  Clinical Pharmacokinetics and Pharmacodynamics of Insulin Lispro Mixtures , 2002, Clinical pharmacokinetics.

[14]  Reed J. Harris,et al.  Effect of Copper Sulfate on Performance of a Serum‐Free CHO Cell Culture Process and the Level of Free Thiol in the Recombinant Antibody Expressed , 2008, Biotechnology progress.

[15]  Hongping Ye,et al.  Simultaneous determination of protein aggregation, degradation, and absolute molecular weight by size exclusion chromatography-multiangle laser light scattering. , 2006, Analytical biochemistry.

[16]  Hongcheng Liu,et al.  Comparison of methionine oxidation in thermal stability and chemically stressed samples of a fully human monoclonal antibody. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[17]  N. Bulleid,et al.  Glutathione Is Required to Regulate the Formation of Native Disulfide Bonds within Proteins Entering the Secretory Pathway* , 2004, Journal of Biological Chemistry.

[18]  R. Kaufman,et al.  The mammalian unfolded protein response. , 2003, Annual review of biochemistry.

[19]  C Russell Middaugh,et al.  Influence of aggregation on immunogenicity of recombinant human Factor VIII in hemophilia A mice. , 2006, Journal of pharmaceutical sciences.

[20]  Huub Schellekens,et al.  'Biogenerics': the off-patent biotech products. , 2002, Trends in pharmacological sciences.

[21]  Douglas S Rehder,et al.  Identification and characterization of deamidation sites in the conserved regions of human immunoglobulin gamma antibodies. , 2005, Analytical chemistry.

[22]  M. Manning,et al.  Stability of Human Serum Albumin During Bioprocessing: Denaturation and Aggregation During Processing of Albumin Paste , 2000, Pharmaceutical Research.

[23]  P. Friedl,et al.  Induction of protein aggregation in an early secretory compartment by elevation of expression level. , 2002, Biotechnology and bioengineering.

[24]  M. Lindgren,et al.  Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy. , 2005, Biophysical journal.

[25]  J L Cleland,et al.  Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2. , 1997, Journal of pharmaceutical sciences.

[26]  Anne Bertolotti,et al.  Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response , 2000, Nature Cell Biology.

[27]  C. Batt,et al.  Cooverexpression of chaperones for enhanced secretion of a single-chain antibody fragment in Pichia pastoris , 2007, Applied Microbiology and Biotechnology.

[28]  J L Cleland,et al.  A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody. , 2001, Journal of pharmaceutical sciences.

[29]  J. Moss,et al.  Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. , 2000, The Journal of biological chemistry.

[30]  I. Braakman,et al.  Protein folding and quality control in the endoplasmic reticulum. , 2004, Current opinion in cell biology.

[31]  Fred Jacobson,et al.  Protein aggregation and bioprocessing , 2006, The AAPS Journal.

[32]  C. Körner,et al.  Quantitative analysis of transcription and translation in gene amplified Chinese hamster ovary cells on the basis of a kinetic model , 2004, Cytotechnology.

[33]  Leszek Konieczny,et al.  An approach to understand the complexation of supramolecular dye Congo red with immunoglobulin L chain λ , 2005, Biopolymers.

[34]  A. Dorner,et al.  Overexpression of GRP78 mitigates stress induction of glucose regulated proteins and blocks secretion of selective proteins in Chinese hamster ovary cells. , 1992, The EMBO journal.

[35]  Y. Lyubarskaya,et al.  Determination of protein oxidation by mass spectrometry and method transfer to quality control. , 2006, Journal of chromatography. A.

[36]  A. Robinson,et al.  Co‐expression of molecular chaperones does not improve the heterologous expression of mammalian G‐protein coupled receptor expression in yeast , 2003, Biotechnology and bioengineering.

[37]  Ryff Jc,et al.  Clinical investigation of the immunogenicity of interferon-alpha 2a. , 1997 .